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Peroxidated Squalene Induces the Production of
Inflammatory Mediators in HaCaT Keratinocytes:
A Possible Role in Acne Vulgaris
Monica Ottaviani1,4, Theodosis Alestas2,4, Enrica Flori1, Arianna Mastrofrancesco1, Christos C. Zouboulis3
and Mauro Picardo1
In order to investigate whether products derived from the oxidation of sebum can be responsible for the
induction of inflammatory processes, HaCaT keratinocytes were treated with peroxidated squalene. NF-kB
activation, secretion, and expression of IL-6, as well as peroxisome proliferator-activated receptor alpha (PPARa)
mRNA and protein levels, were measured at the end of the treatment and after 24 and 48 hours of recovery.
Squalene peroxidation products were administered in amounts able to elicit significant hyperproliferation and
to induce lipoxygenase (LOX) activity. The results showed an early activation of NF-kB followed by an increase in
PPARa mRNA and protein levels. Moreover, squalene peroxides induced an initial upregulation of IL-6
production and secretion that was counteracted by PPARa activation, as suggested by the subsequent decrease
of NF-kB nuclear translocation and IL-6 levels. Inflammatory processes play an important role in the
development of acne vulgaris. In combination with our own previous findings, which indicated an association
between LOX stimulation and increased percentage of proinflammatory lipids in acne as well as a correlation
between increased cytokine levels in the infundibulum, pilosebaceous duct hyperkeratinization, and
augmented sebogenesis, the present data further support the involvement of lipid peroxides, in particular
squalene peroxides, in establishing an inflammatory process in acne.
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INTRODUCTION
Sebum is a holocrine product of human sebocytes partially
constituted of a complex mixture of lipids. Owing to the
presence of unsaturated lipids, sebum may undergo a
process of peroxidation under the action of physical,
chemical, and biological agents giving rise to proinflamma-
tory lipidic by-products (Nazzaro-Porro et al., 1986).
Squalene is a characteristic human sebaceous lipid. The
presence of six double bonds allows squalene to easily
undergo a photo-oxidation process giving rise to squalene
mono-hydroperoxide as the principal product (Kohno et al.,
1993) together with several by-products (Picardo et al.,
1991a). Squalene peroxides (peroxidated squalene (P-Sq))
have been demonstrated to be involved in the pathogenesis of
certain skin conditions (Ohkido et al., 1980; Ohsawa et al.,
1984; Nazzaro-Porro et al., 1987; Picardo et al., 1991b) and
to exert a comedogenic effect with a reaction degree higher
than that of other peroxides (Motoyoshi, 1983; Chiba et al.,
2000). Moreover lipids from comedones in acne patients
seem to be enriched in P-Sq, indicating a possible role of this
peroxides in the development of acne lesions (Saint-Leger
et al., 1986a).
Acne is a disease of the pilosebaceous unit affecting – at
different degrees of severity – about 85% of adolescents. Its
pathogenesis is complex and is dependent on the interplay of
multiple factors such as genetic predisposition, excess of
sebum production, regulation of peroxisome proliferator-
activated receptors (PPARs), abnormal follicular proliferation,
and development of inflammation (Zouboulis et al., 2005a, b).
The sequence of events has not been elucidated yet, but
current data indicate that inflammation could be a primary
triggering factor and that Propionibacterium acnes is not the
cause of initial acne lesions but a significant contributing
element to the inflammatory stages of the disease (Zouboulis,
2001; Farrar and Ingham, 2004; Zouboulis et al., 2005a).
Although excess of sebum excretion is involved in the
pathophysiology of acne (Zouboulis, 2004), it is still unclear
whether it is associated with the severity of the disease (Pochi
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and Strauss, 1964; Cunliffe and Shuster, 1969; Burton and
Shuster, 1971; Cunliffe, 1989; Youn et al., 2005). Changes
in secretion rates and composition of sebum seem to be
associated with hyperproliferation of the keratinocytes lining
the follicle wall during comedogenesis (Downing et al.,
1986). On the other hand, the quality of lipids and not the
quantity has currently been addressed as a probable initiator
of inflammatory processes (Cordain, 2005; Zouboulis et al.,
2005a).
Lipoxygenases (LOXs) are enzymes involved in the
lipoperoxide formation, and the products of their action are
thought to participate in the development of inflammatory
skin lesions also by inducing keratinocytes hyperprolifera-
tion, such as psoriasis and atopic dermatitis (Iversen
et al., 1997; Yokomizo et al., 2001; Haeggstrom and
Wetterholm, 2002). Recent evidence indicates a role for
LOX products, such as leukotrienes B4 (LTB4), in the
development of inflammatory acne lesions (Zouboulis,
2003; Alestas et al., 2006). Preliminary clinical studies have
shown that a specific inhibitor of 5-LOX reduces the number
of inflammatory lesions and the levels of sebum peroxides in
acne patients, supporting the hypothesis that lipoperoxides
may exert a proinflammatory action on the pilosebaceous
unit (Zouboulis et al., 2003, 2005b).
The aim of this study was to investigate the possible role of
P-Sq in the initiation and development of inflammatory
events using a human keratinocytes cell line (HaCaT) as
model. We evaluated the effect of P-Sq on HaCaT keratino-
cytes proliferation and LOX activity. Among the inflammatory
pathways, we focused on the activation of NF-kB, which
coordinates the expression of different proinflammatory
genes, synthesis and secretion of the cytokine IL-6, and
induction of PPARa. The latter inhibits the synthesis of
proinflammatory molecules, such as IL-6, via a decreased
activity of the NF-kB signalling pathway (Poynter and
Daynes, 1998; Staels et al., 1998; Delerive et al., 1999,
2001; Marx et al., 1999), and it is likely to exhibit a role in
acne (Zouboulis et al., 2005b; Alestas et al., 2006). We could
show that P-Sq stimulates HaCaT keratinocytes proliferation,
LOX activity, and NF-kB activation with the consequent
secretion of IL-6. Finally, P-Sq induces mRNA and protein
PPARa expression that leads to NF-kB inhibition and
decreased IL-6 levels. These results indicate a direct
involvement of P-Sq in the onset of inflammatory state.
Considering that Sq is a specific human sebaceous product
and that its peroxidation products exert a comedogenic
effect, our own previous data indicate the involvement of
P-Sq in the development of inflammation in acne.
RESULTS
Proliferative effect of P-Sq on HaCaT keratinocytes
In order to evaluate a possible role of P-Sq on the
hyperkeratinization of the pilosebaceous duct, we focused
on the proliferation response of HaCaT keratinocytes after
treatment with P-Sq in a concentration range from 0.1 to
10 mg/ml by means of the 3-(4,5-dimethyl-thiazolyl-2)-2,
5-diphenyltetrazolium bromide (MTT) test and cell counting.
P-Sq exerted different effects on HaCaT cell proliferation
depending on the concentration administered. In particular,
concentrations below 0.75 mg/ml did not affect HaCaT
keratinocytes proliferation, whereas concentrations between
0.75 and 5.0 mg/ml induced a significant proliferative
stimulus (approximately 30%, Po0.05) and higher concen-
trations began to have a toxic effect proportional to P-Sq dose
(Figure 1a). Cell counting confirmed the results obtained with
the MTT assay and indicated a dose-dependent effect of P-Sq
(R2¼0.92) (Figure 1b). Sq treatment (0.1–5 mg/ml) did not
affect HaCaT keratinocytes proliferation and resulted in a
toxic effect at higher concentrations (Figure 1a). These data
suggest that P-Sq may be involved in the induction of the
hyperkeratosis of the pilosebaceous duct.
Induction of LOX activity in HaCaT keratinocytes by P-Sq
Our own previous data indicated that lipoperoxides and
sebum production could be related to 5-LOX activity in
acne patients (Zouboulis et al., 2003, 2005a, b). In order to
investigate whether P-Sq could stimulate LOX activity, we
evaluated linoleic acid (LA) consumption in control- and
P-Sq-treated HaCaT keratinocytes by gas chromatography–mass
spectrometry (GC–MS). Cells treated with P-Sq consumed
approximately 30% more LA than untreated ones (Figure 2).
The experiment was further conducted by preincubating the
cells with 5,8,11,14-eicosatetraynoic acid, a broad LOX
inhibitor that completely abrogated LA cell consumption by
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Figure 1. P-Sq exerts a proliferative effect on HaCaT keratinocytes.
Keratinocytes were treated with P-Sq and Sq (0.1–10 mg/ml) for 3 hours in
serum-free conditions, incubated with an MTT solution for 2 hours at 371C,
and lysed by dimethylsulfoxide. All values are related to control ones derived
from untreated cells. (a) The data are reported as percentage of absorbance at
570 nm in comparison with the control. (b) Cell proliferation was determined
also by the Trypan blue exclusion test. After treatment, HaCaT keratinocytes
were harvested and counted using a hemocytometer. The shown values are
the mean7SD of three experiments in triplicate. Statistical differences were
evaluated using Mann–Whitney test (*Po0.05 with respect to untreated cells).
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HaCaT keratinocytes (Figure 2). These results demonstate that
P-Sq stimulates LOX activity leading to the generation of
proinflammatory mediators.
Induction of NF-jB activation
To investigate the potential effect of P-Sq on the induction
of inflammatory response in HaCaT keratinocytes, NF-kB
activation was determined by FACS analysis in control- and
P-Sq-treated cells. A significant increase in NF-kB activation
was observed in P-Sq-treated HaCaT keratinocytes, when
compared to controls, just after 1 hour of treatment (Figure 3).
This induction was maintained at an elevated level up to
2 hours after P-Sq withdrawal, reaching again the basal level
after 24 hours. Sq did not activate the NF-kB pathway.
Considering that the majority of the proinflammatory genes
are under the control of the NF-kB signalling pathway, it is
likely that P-Sq can induce the production of inflammatory
mediators in HaCaT keratinocytes.
Induction of IL-6 expression and secretion in HaCaT keratino-
cytes by P-Sq
Among keratinocyte-derived cytokines and chemokines, the
proinflammatory ones IL-1, IL-6, IL-8, and tumor necrosis
factor-a are best characterized (Grone, 2001). In order to
verify whether P-Sq treatment can be responsible for the
development of inflammatory reaction in keratinocytes, we
focused our interest on IL-6 induction and secretion. We
observed, by means of fluorimetric analysis, an increase in
the release of IL-6 in HaCaT keratinocytes treated with P-sq at
a concentration of 1, 2, and 5 mg/ml for 24 hours after P-Sq
removal (control: 20076 pg/ml; P-Sq 1 mg/ml: 262712 pg/
ml; P-Sq 2 mg/ml: 262713 pg/ml; P-Sq 5 mg/ml: 293715 pg/
ml; Po0.05). Cytokine release began to decrease 48 hours
after treatment (P-Sq 1 mg/ml: 238713 pg/ml; P-Sq 2 mg/ml:
239715 pg/ml; P-Sq 5 mg/ml: 243716 pg/ml; Po0.05)
(Figure 4). The evaluation of IL-6 mRNA levels confirmed
the results derived from the protein studies. An upregulation of
IL-6 mRNA levels in a dose-dependent manner was observed
in cells treated with P-Sq at 1, 2, and 5 mg/ml compared to
controls, immediately after the treatment (P-Sq 1 mg/ml:
109%73; P-Sq 2 mg/ml: 118%74; P-Sq 5 mg/ml: 133%75;
Po0.05; R240.9). The level of IL-6 gene expression in
treated cells remained steady up to 24 hours after P-Sq
removal (P-Sq 1 mg/ml: 113%73; P-Sq 2 mg/ml: 119%73;
P-Sq 5mg/ml: 136%74; Po0.05), returning again to the control
level after 48 hours (P-Sq 1 mg/ml: 104%71; P-Sq 2 mg/ml:
106%71; P-Sq 5 mg/ml: 111%71; Po0.05) (Figure 5). P-Sq
at 0.75mg/ml and Sq did not affect IL-6 expression and
secretion (Figures 4 and 5). The results obtained demonstrate
that P-Sq is able to induce an inflammatory stimulus in
HaCaT keratinocytes by increasing IL-6 expression and
secretion.
Induction of PPARa mRNA and protein expression in HaCaT
keratinocytes by P-Sq
In order to investigate the machinery of the inflammatory
response more thoroughly, we evaluated the P-Sq effect on
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Figure 2. P-Sq is able to induce HaCaT LOX activity. Directly or after
a pretreatment with 5,8,11,14-eicosatetraynoic acid (10 mM), HaCaT
keratinocytes were treated with P-Sq and Sq (0.75–5.0 mg/ml) for 3 hours in
serum-free conditions. LA was added to the cell lysates and, after the
incubation at 371C for 12 minutes, its amount was evaluated by GC–MS
analysis. (a) A representative chromatogram is shown. Nonadecanoic acid
was used as an internal standard (IS). (b) LA recovery presentation. The results
are expressed as percentage of residual LA after the incubation in comparison
with untreated cells. The values shown are mean7SD representative of three
experiments in duplicate. Statistical differences were evaluated using the
Mann–Whitney test (*Po0.02 with respect to untreated cells, 1Po0.02 with
respect to P-Sq-treated cells).
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Figure 3. P-Sq induces NF-jB nuclear translocation in HaCaT keratinocytes.
Keratinocytes were treated with P-Sq and Sq (0.75–5.0 mg/ml) for 1 and
3 hours under serum-free conditions. Nuclei isolation was performed by the
Cycle TEST
TM
PLUS DNA Reagent kit immediately after the treatment and 2
and 24 hours after the P-Sq and Sq depletion. NF-kB was detected by a mAb
and analyzed by flow cytometer. Results are expressed as percentage of
positive cells and represent the mean7SD of three experiments in duplicate.
Statistical differences were evaluated using the Mann–Whitney test (*Po0.01
with respect to untreated control, **Po0.005 with respect to untreated
control, 1Po0.01 with respect to cells treated with P-Sq for 1 hour).
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mRNA expression and protein synthesis of PPARa, which
plays an important role in the inflammatory cascade
(Delerive et al., 2001). Immediately after treatment, P-Sq at
1, 2, and 5 mg/ml caused an upregulation of PPARa mRNA
levels compared to controls (P-Sq 1 mg/ml: 138%72; P-Sq
2 mg/ml: 142%74, P-Sq 5mg/ml: 150%74; Po0.05). After-
wards, the level of PPARa gene expression in the treated
cells decreased during the following 48 hours. Conversely,
the treatment of HaCaT keratinocytes with P-Sq at 0.75 mg/ml
or Sq did not exert any effect on the expression pattern of
PPARa, compared to untreated controls (Figure 6). Significant
upregulation of PPARa protein levels was observed by means
of Western blot analysis in cells treated with P-Sq at 1, 2, and
5 mg/ml compared to controls, 24 hours after P-Sq removal
(P-Sq 1mg/ml: 130%73; P-Sq 2mg/ml: 135%74; P-Sq 5mg/ml:
154%74; Po0.05). Sq did not exert any effect on PPARa
protein levels (Figure 7). The PPARa upregulation supports
*
** ¡ ¡ ¡
0
50
100
150
200
250
300
350
Ctr Sq P-Sq 0.75
g/ml g/ml g/ml g/ml
P-Sq 1 P-Sq 2 P-Sq 5
pg
/m
l
3 hours + 24 hours rec
3 hours + 48 hours rec
Figure 4. P-Sq induces an upregulation of HaCaT keratinocytes IL-6
secretion. HaCaT keratinocytes were treated with P-Sq and Sq (0.75–5.0 mg/
ml) for 3 hours under serum-free conditions and collected 24 and 48 hours
after P-Sq and Sq depletion. IL-6 release was determined by Fluorokines
MAP cytokine multiplex kits using a Bioplex reader. All values are related to
control ones derived from untreated cells. Results are expressed as average
mean of protein concentration (pg/ml)7SD and represent the mean of three
experiments in duplicate. Statistical differences were evaluated using the
Mann–Whitney test (*Po0.05 with respect to untreated control, 1Po0.05
with respect to treated cells 24 hours after P-Sq removal).
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Figure 5. P-Sq is able to upregulate IL-6 mRNA expression in HaCaT
keratinocytes. HaCaT keratinocytes were treated with P-Sq and Sq
(0.75–5.0 mg/ml) for 3 hours in serum-free conditions and collected 24 and
48 hours after P-Sq and Sq depletion. For each sample, the same amount
(1 mg) of total mRNA was reverse transcribed into cDNA and amplified by
PCR reaction. The PCR products were visualized on agarose gel and the band
intensities were evaluated by densitometric analysis. The values shown
represent mean7SD of three experiments. Statistical differences were
evaluated using the Mann–Whitney test (*Po0.05 with respect to untreated
control, 1Po0.05 with respect to treated cells after P-Sq removal).
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Figure 6. P-Sq induces an upregulation of PPAR-a mRNA level in HaCaT
keratinocytes. HaCaT keratinocytes were treated with P-Sq and Sq
(0.75–5.0 mg/ml) for 3 hours under serum-free conditions and collected at the
end of the treatment and 24 and 48 hours after P-Sq and Sq depletion. For
each sample, the same amount (1 mg) of total mRNA was reverse transcribed
into cDNA and amplified by PCR reaction. The PCR products were visualized
on agarose gel and the band intensities were evaluated by densitometric
analysis. The values shown represent mean7SD of three experiments.
(a) Statistical differences were evaluated using the Mann–Whitney test
(*Po0.05 with respect to untreated control, 1Po0.05 with respect to treated
cells after P-Sq removal). (b) PCR amplification of PPAR-a representative data
is shown. Lanes 1–9: untreated HaCaT; lanes 2–10: HaCaT treated with Sq;
lanes 3 and 11: HaCaT treated with P-Sq 0.75 mg/ml for 3 hours; lanes 4
and 12: HaCaT treated with P-Sq 1 mg/ml for 3 hours; lanes 5 and 13: HaCaT
treated with P-Sq 2 mg/ml for 3 hours; lanes 6 and 14: HaCaT treated with P-Sq
5mg/ml; lane 7: negative control; lane 8: molecular weight marker, 10 ml of
100 bp DNA ladder (Promega).
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Figure 7. P-Sq induces an upregulation of PPARa protein levels in HaCaT
keratinocytes. HaCaT keratinocytes were treated with P-Sq and Sq
(0.75–5.0 mg/ml) for 3 hours in serum-free conditions and collected 24 hours
after P-Sq and Sq depletion. Twenty micrograms of total cell lysate proteins
was resolved under reducing conditions and transferred to nitrocellulose
membrane. The membrane was incubated for 1 hour at room temperature,
with a monoclonal antibody against PPARa (clone 3B6). As secondary
antibody, goat anti-mouse IgG-HRP was used, followed by ECL detection.
The band intensities were evaluated by densitometric analysis. The values
shown represent the mean7SD of three experiments. (a) Statistical differences
were evaluated using the Mann–Whitney test (*Po0.05 with respect to
untreated control). (b) Representative blot is shown. Lane 1: untreated HaCaT;
lane 2: HaCaT treated with Sq; lane 3: HaCaT treated with P-Sq 0.75 mg/ml
for 3 hours; lane 4: HaCaT treated with P-Sq 1 mg/ml for 3 hours; lane 5:
HaCaT treated with P-Sq 2 mg/ml for 3 hours; lane 6: HaCaT treated with
P-Sq 5 mg/ml for 3 hours.
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the data mentioned above, which highlighted the possible
induction of inflammatory response in HaCaT keratinocytes
after the treatment with P-Sq.
DISCUSSION
In this study, we investigated the potential role of photo-
oxidation products of Sq (P-Sq), a characteristic sebaceous
lipid, in the induction of inflammatory mediators.
Treatment of the human keratinocyte cell line HaCaT
with P-Sq in a certain concentration range stimulated cell
proliferation and LOX activity. P-Sq treatment also induced
enhancement of NF-kB nuclear translocation followed by an
increase in the expression and secretion of the proinflamma-
tory cytokine IL-6 and enhancement of PPARa mRNA and
protein levels.
Sebaceous duct keratinocytes from comedones exhibit a
hyperproliferative response compared to normal keratino-
cytes (Knaggs et al., 1994; Huges et al., 1996). The hyper-
proliferative behavior of HaCaT keratinocytes induced by
P-Sq could support the idea that different sebum compositions
may be involved in comedone formation and, in particular,
that Sq peroxides could be – at least partially – responsible
for this event. P-Sq seems to be involved in early stages of
the inflammatory response and it also probably plays an
important role in sustaining it through activation of LOX.
HaCaT keratinocytes treated with Sq peroxide at concentra-
tions inducing hyperproliferation exhibited increased LOX
activity. LOX are enzymes involved in the lipoperoxide
formation and their products are suggested to participate in
the development of inflammatory skin diseases with kerati-
nocyte hyperproliferation, such as psoriasis and atopic
dermatitis (Iversen et al., 1997; Yokomizo et al., 2001;
Haeggstrom and Wetterholm, 2002). A LOX involvement in
the pathogenesis of acne has recently been suggested, in
particular LTB4 synthesis through 5-LOX (Zouboulis, 2001;
Zouboulis, 2003; Alestas et al., 2006). LTB4 is a potent
chemoattractant agent being able to recruit neutrophils
and macrophages, and its production could justify the initial
neutrophil infiltration described in acne leading to inflam-
matory lesions also in the absence of P. acnes (Yokomizo
et al., 2001; Jeremy et al., 2003). LTB4 synthesis is increased
by inflammatory mediators and LTB4 itself stimulates the
production of a number of proinflammatory cytokines,
indicating its ability to increase and prolong the inflammatory
stage (Crooks and Stockley, 1998). The presence of an
inflammatory stimulus after treatment with P-Sq was demon-
strated by the concentration-dependent activation of NF-kB
with the consequent increase in the expression and secretion
of IL-6. We focused on IL-6 because it is one of the best-
characterized proinflammatory cytokines in keratinocytes,
which is expressed under a variety of conditions (Grone,
2002). IL-6 stimulates keratinocyte proliferation (Grossman
et al., 1989; Sato et al., 1999; Sugawara et al., 2001) and
its transcription is controlled by PPARa (Delerive et al.,
2001). PPARa exerts a modulatory role in the control of
the inflammatory response (Devchand et al., 1996; Delerive
et al., 2001; Kota et al., 2004) by antagonizing NF-kB and
AP-1 signalling pathways (Poynter and Daynes, 1998; Staels
et al., 1998; Delerive et al., 1999; Marx et al., 1999). After the
treatment with P-Sq, HaCaT keratinocytes exhibited higher
levels of PPARa transcripts probably as a feedback in anti-
inflammatory response to the stimulus. Moreover, the fact
that NF-kB activation and IL-6 values return to basal levels
with the increase of PPARa expression allows us to speculate
that it may be owing to PPARa action.
In conclusion, we demonstrated that squalene peroxide
can induce an inflammatory response in keratinocytes
through LOX activation and increase in the proinflammatory
cytokine IL-6 production. Therefore, we suggest that the
products of LOX activity may contribute to an implementa-
tion of the inflammatory reaction with a concomitant
anti-inflammatory feedback response of (healthy) keratino-
cytes as demonstrated by the increase of PPARa mRNA and
protein levels.
As shown before, systemic treatment with a 5-LOX
inhibitor reduces the inflammatory lesions in acne patients
with the concomitant decrease of sebum hydroperoxides
amount, indicating that these compounds have a role in the
pathogenesis of acne exerting proinflammatory activity on
the pilosebaceous unit (Zouboulis, 2003). Moreover, pre-
viously published in vivo study demonstrated that skin
surface lipids from acne patients, in comparison to healthy
subjects, were enriched in polar lipids that appeared to be
derived mainly from Sq oxidation as confirmed by in vitro
study (Saint-Leger et al., 1986a, b). These and our present
findings allow us to suggest a possible role of P-Sq in the
development of acne lesions.
MATERIALS AND METHODS
Cell culture
The spontaneously immortalized human keratinocyte cell line
(HaCaT) (Boukamp et al., 1988) was cultured in DMEM (Euroclone,
Wetherby, West York, UK), supplemented with fetal bovine serum
(10%), L-glutamine (2 mM), penicillin (100 mg/ml), and streptomycin
(100mg/ml) (all from GIBCO, Milan, Italy) at 371C in 5% CO2/95%
air atmosphere in a humidified incubator.
Sq peroxidation
Squalene (1 mg/ml) in hexane was UVA irradiated (365 nm) using
a UVA lamp with an output of 17.6 mW/cm2 for 1 hour at a distance
of 30 cm (Psorisans 900, Dr Ho¨nle Medizintechnik, Munich,
Germany). The amount of P-Sq was determined by a Lambda 25
UV/Vis spectophotometer (Perkin-Elmer, Bucks, UK) according
to a method using dietyl-para-phenilendiamine (DEPD) as reagent
(Nazzaro-Porro et al., 1986).
Treatments
Cell proliferation. HaCaT keratinocytes were seeded in 24-well
plates (2 104 cells per well) and treated in serum-free conditions
for 3 hours with Sq or P-Sq at concentrations of 0.1, 0.25, 0.5, 0.75,
1, 2, 5, and 10 mg/ml. At the end of the treatment, fresh medium was
added and cell proliferation was determined after 24 hours.
LOX activity. HaCaT keratinocytes were seeded in 25 cm2 culture
flasks (5 105 cells per flask) and treated in serum-free conditions
with Sq or P-Sq (0.75, 1, 2, and 5 mg/ml) for 3 hours. In a part of the
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experiments, cells were pretreated for 48 hours with 5,8,11,14-
eicosatetraynoic acid (10 mM) (Sigma-Aldrich, Milan, Italy). Cells
were analyzed at the end of the treatments or after 24 hours from the
addition of fresh medium.
NF-kB activation. HaCaT keratinocytes were seeded in six-well
plates (2 105 cells per well) and treated in serum-free conditions
with Sq or P-Sq (0.75, 1, 2, and 5mg/ml) for 1 and 3 hours,
respectively. Cells were analyzed at the end of the treatments or after
24 hours from the addition of fresh medium.
IL-6 and PPARa mRNA expression. HaCaT keratinocytes were
seeded in 75 cm2 culture flasks (2 106 cells per flask) and treated in
serum-free conditions with Sq or P-Sq (0.75, 1, 2, and 5mg/ml) for
3 hours. Cells were collected at the end of the treatment or after 24
and 48 hours from the addition of fresh medium.
PPARa protein expression. HaCaT keratinocytes were seeded in
75 cm2 culture flasks (2 106 cells per flask) and treated in serum-
free conditions with Sq or P-Sq (0.75, 1, 2, and 5mg/ml) for 3 hours.
Cells were collected after 24 and 48 hours from the addition of fresh
medium.
IL-6 release. HaCaT keratinocytes were seeded in 24-well plates
(2 104 cells per well) and treated in serum-free conditions with Sq
and P-Sq (0.75, 1, 2, and 5mg/ml) for 3 hours. At the end of the
treatment, surnatants were removed, fresh medium was added, and
free cell supernatants were collected after 24 and 48 hours.
Cell proliferation
Cell proliferation was evaluated by MTT assay (Sigma-Aldrich). Cells
were incubated with an MTT solution (final concentration 0.5 mg/
ml) for 2 hours at 371C and lysed by dimethyl sulfoxide. Absorbance
at 570 nm was measured by a spectrophotometer mQUANT (BIO-
TEK). The results represent the mean of three experiments in
triplicate. In addition, cell proliferation was also determined by the
Trypan blue exclusion test. Cells were harvested by incubation in
0.5% trypsin and 0.2% EDTA for 10 minutes at 371C, and counted
using a hemocytometer. The results represent the mean of three
experiments in triplicate.
LOX activity
LOX activity was evaluated by maintaining GC–MS the consumption
of LA, the substrate of the enzyme, added to the cell lysates. Treated
cells were lysed in TRIS-EDTA-EGTA (TEE) buffer (50 mM Tris/
HCl pH 8.5, 1 mM EDTA (both from Merck, Darmstadt, Germany),
1 mM EGTA and 10 mg/ml leupepetin (both from Sigma-Aldrich)) by
repeated freezing in liquid nitrogen and thawing. Protein concentra-
tion was determined in the supernatants according to Bradford
(Bradford, 1976), using BSA as a standard, by a Lambda 25 UV/Vis
spectophotometer (Perkin-Elmer, UK). Aliquots of supernatants
containing 150mg of proteins were diluted to 250 ml with TEE buffer,
and were incubated with LA dissolved in 5 ml of ethanol (final
concentration 100mM) for 12 minutes at 371C (Siebert et al., 2001).
The reaction was terminated by adding 40ml of sodium formate
buffer (1 M, pH 3.1) and 100 ml of nonadecanoic acid (100 mg/ml;
both from Sigma-Aldrich) was added as internal standard for GC–MS
analysis. Samples were extracted twice with ethyl acetate and the
combined organic extracts were evaporated under N2 flow. The
samples were then methylated by adding 500 ml of diazomethane.
After 30 minutes at room temperature, the samples were dried under
N2 flow, dissolved in 100ml of ethyl acetate, and analyzed using a
combined GC–MS system (Trace GC Ultra, Thermofinnigan
equipped with a single quadrupole mass spectrometer Trace
DSQ, Thermofinnigan) on capillary column (RTX-5MS 30 m
0.25 mm 0.25mm, Restek, Bellefonte, PA). Helium was used as
the carrier gas. An oven temperature gradient from 40 to 2801C at
101C/minute was used. Mass spectra were recorded in Electronic
Impact and in SIM modality (tR(LA)¼ 23 minutes (m/z 81, 294)
tR(IS)¼ 24.10 minutes (m/z 143, 312)). The results were obtained
after time integration of chromatogram and final reprocessing of
the peak areas. They were reported as a percentage of residual LA.
The results represent the mean of three experiments in triplicate.
NF-jB activation
HaCaT keratinocytes were trypsinized, centrifuged at 200 g,
resuspended in phosphate-buffered saline solution (PBS; Euroclone
LTD, UK), and washed twice. Determination of NF-kB activation
was performed using the Cycle TESTTM PLUS DNA Reagent
Kit, according to the manufacturer’s procedure (Becton-Dickinson,
Mountain View, CA). Briefly, cells were resuspended in the buffer
solution and centrifuged at 200 g twice. Then, cells were
incubated with anti-NF-kB p65 mouse monoclonal antibody
(1:1,000 in PBS) for 10 minutes followed by goat anti-mouse IgG-
FITC antibody (1:100 in PBS) (both from Santa Cruz Biotechnology,
Italy). The samples were analyzed on a FACSCalibur flow cytometer
(Becton-Dickinson) equipped with a 488 nm argon laser. A total of
1 104 cells from each sample were acquired, and CELL-QUEST
software was used to analyze the data. H2O2 (0.2 mM) treatment was
used as NF-kB activation-positive control. The results represent the
mean of three experiments in triplicate.
IL-6 release
IL-6 release into the supernatants was assessed using the Fluoro-
kines MAP cytochine multiplex kits (R&D Systems, UK), designed
to be used in a BioplexTM reader (Bio-Rad, Milan, Italy). The assay
was performed according to the manufacturer’s instructions. The
results represent the mean of three experiments in triplicate.
RNA isolation
Total RNA from HaCaT keratinocytes was isolated using the Trizol
method (Invitrogen, Italy) according to the manufacturer’s proce-
dure, and stored at 801C until use.
Reverse transcriptase-PCR
The oligonucleotide primers for PCR were synthetized by MWG-
Biotech AG (Italy) and were as follows: glyceraldehyde-3-phosphate
dehydrogenase sense: 50-GCACCACCAACTGCTTAGC-30 and anti-
sense: 50-TGCTCAGTGTAGCCCAGG-30; IL-6 sense: 50-TGAACCTT
CCAAAGATGGCTG-30 and antisense: 50-ACATTTGCCGAAGAGCC
CTC-30; PPAR-a sense: 50-TGTCGGGATGTCACACAACG-30 and
antisense: 50-TGGTTCCATGTTGCCAAGAG-30.
Reverse transcriptase-PCR was carried out using 1 mg of total
RNA. After denaturation in diethylpyrocarbonate-treated water
(Promega Corporation, Madison, WI) at 701C for 10 minutes, RNA
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was reverse transcribed into cDNA using ImProm-IITM Reverse
Transcriptase (1ml per reaction; Promega) and 0.5 mg of oligo(dT)
primers, at 421C for 60 minutes, in a total volume of 20 ml ImProm-
IITM 5 Reaction Buffer (Promega), containing 1.5 mM MgCl2,
0.5 mM dNTP, and 20 U RNase inhibitor. Reverse transcriptase was
inactivated at 701C for 15 minutes and the RNA template was
digested by RNase H at 371C for 30 minutes. In each case, samples
containing no reverse transcriptase (negative control) were included
to exclude amplification from contaminating DNA. PCR reaction
was carried out in the PCR Master Mix buffer (25 ml total volume;
Promega) containing 1 ml cDNA, 20 pmol of oligonucleotide
primers, 1 U Taq DNA polymerase, 1.5 mM MgCl2, and 0.2 mM
dNTP. PCR amplification was performed with an iCycler thermal
cycler (Bio-Rad). Each cycle consisted of 1 minute at 941C, 1 minute
at annealing temperature, and 1 minute at 721C, for a total of 32
cycles. The final product was extended for 5 minutes at 721C. In
every case, PCR-negative control (without DNA) was included. PCR
conditions were as follows (annealing temperature, amplicon
length): glyceraldehyde-3-phosphate dehydrogenase: 551C, 382 bp;
IL-6: 56.11C, 369 bp; PPAR-a: 551C, 269 bp. The PCR products were
visualized on 1.5% w/v agarose gel by staining with ethidium
bromide.
Quantification of PCR products
To semiquantify the relative amounts of PPAR-a or IL-6 mRNA, the
band intensities of amplified products were related densitometrically
to the signal intensity of the respective glyceraldehyde-3-phosphate
dehydrogenase PCR product of the same sample. Densitometrical
evaluation was performed using a UVIDocMw software (Bio-Rad).
Results from three different experiments were taken and expressed as
percent of the control.
Western blot analysis
HaCaT keratinocytes were lysed in RIPA buffer (10 mM Tris pH 7.2,
150 mM NaCl, 0.1% SDS, 1% Triton, 1% deoxycholate, and 5 mM
EDTA) supplemented with protease inhibitors (1mM leupeptin,
aprotinin, pepstatin A, and 1 mM PMSF). The protein content was
determinated with the Bio-Rad protein assay and BSA for calibration.
Twenty micrograms of total cell lysate proteins was resolved under
reducing conditions using 8% SDS-polyacrylamide gel and trans-
ferred to nitrocellulose membrane (Amersharm Biosciences Co.,
Arlington Heights, IL). Protein transfer was checked with Ponceaus
staining (Sigma), and after washing with PBS, the membrane was
blocked with 5% non-fat dry milk in PBS with 0.05% Tween 20 for
1 hour at room temperature. After washing for 30 minutes in PBS and
0.05% Tween 20, the membrane was incubated with mAb against
PPARa (clone 3B6, diluition 1:1,000) (Alexis Corporation, Switzer-
land) for 1 hour at room temperature. As a secondary antibody, goat
anti-mouse IgG-HRP (diluition 1:1,000) (Santa Cruz Biotechnology
Inc., Santa Cruz, CA) was used, followed by ECL detection.
Statistical analysis
Values represent mean value7SD. Statistical differences were
evaluated using the Mann–Whitney test. Mean differences were
considered to be significant when Po0.05.
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